MedPath

"Role of Tranexamic Acid (TXA) to reduce the bleeding in post delivery cases"

Phase 3
Not yet recruiting
Conditions
Postpartum Haemorrhage (PPH)
Registration Number
CTRI/2012/05/002622
Lead Sponsor
Indian Council of Medical Research ICMR
Brief Summary

The women Trail aims to determine the effect of the early adminstration of Tranexamic acid on mortality, hysterectomy and other morbidities (surgical interventions, blood tranfusion, risk of nonfatal vascular events) in woman with clinically diagonsed postpartum haemorrhage. the use of health services and safety, espically thromoboembolic effect, on brestfeed babies will also be assessed.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
15000
Inclusion Criteria
  • All legally adult women with clinically diagnosed postpartum haemorrhage following vaginal delivery of a baby or caesarean section; women may have delivered their babies at a participating hospital of outside a participating hospital, with hospital admission following delivery: Where the responsible clinician is substantially uncertain as to whether or not to use TXA When consent has been given according to approved procedures.
  • The clinical diagnosis of PPH may be based on any of the following: Estimated blood loss after vaginal delivery of a baby >500 mL OR >1000 mL from caesarean section OR Estimated blood loss enough to compromise the haemodynamic status of the woman.
Exclusion Criteria
  • Women for whom the responsible clinician considers there is a clear indication for TXA should not be randomized.
  • Women for whom the responsible clinician considers there is a clear contraindication for TXA should not be randomized (e.g. a known thrombembolic even during pregnancy).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome is the proportion of women who die or undergo hysterectomy. the primary cause of death will be described.6 weeks
Secondary Outcome Measures
NameTimeMethod
a) Deathb) surgical interventions: including hysterectomy, brace suture (b-lynch/cho), selective arterial

Trial Locations

Locations (20)

All India Institute of Medical Sciences

🇮🇳

South, DELHI, India

Chhatrapati Shahuji Maharaj Medical University, Lucknow

🇮🇳

Lucknow, UTTAR PRADESH, India

EDEN, KOLKATA

🇮🇳

Kolkata, WEST BENGAL, India

Government Rajaji Hospital, Madurai

🇮🇳

Madurai, TAMIL NADU, India

Govt Medical College, SMGS Hospital, Jammu

🇮🇳

JAMMU, & KASHMIR, India

Grants Medical College & Sir JJ Group of Hospitals Mumbai

🇮🇳

Mumbai, MAHARASHTRA, India

GSVM Medical College, Kanpur

🇮🇳

Nagar, UTTAR PRADESH, India

Institute of Obstetrics and Gynecology,Chennai

🇮🇳

Chennai, TAMIL NADU, India

Jawaharlal Institute of Postgraduate Medical Education & Reserach (JIPMER)

🇮🇳

Pondicherry, PONDICHERRY, India

Jawaharlal Nehru Medical College, Belgaum

🇮🇳

Belgaum, KARNATAKA, India

Scroll for more (10 remaining)
All India Institute of Medical Sciences
🇮🇳South, DELHI, India
Dr Suneeta Mittal
Principal investigator
01126593378
suneeta.mittal@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.